Use your antibodies-online credentials, if available.
抗Human SRSF1 抗体:
抗Mouse (Murine) SRSF1 抗体:
抗Rat (Rattus) SRSF1 抗体:
Human Polyclonal SRSF1 Primary Antibody for ICC, IF - ABIN4353084
Brown, Dobrikov, Gromeier et al.: Mitogen-activated protein kinase-interacting kinase regulates mTOR/AKT signaling and controls the serine/arginine-rich protein kinase-responsive type 1 internal ribosome entry site-mediated ... in Journal of virology 2014
Show all 2 Pubmed References
Cow (Bovine) Polyclonal SRSF1 Primary Antibody for IHC, WB - ABIN2779013
Velazquez-Dones, Hagopian, Ma, Zhong, Zhou, Ghosh, Fu, Adams: Mass spectrometric and kinetic analysis of ASF/SF2 phosphorylation by SRPK1 and Clk/Sty. in The Journal of biological chemistry 2005
Show all 2 Pubmed References
DLP (显示 DMD 抗体) and ASF1 are part of a predeposition complex, which is recruited by XNP (显示 ATRX 抗体) and is necessary to prevent DNA exposure in the nucleus.
ASF1 cellular levels are tightly controlled by distinct pathways and provide a molecular mechanism for post-translational regulation of dASF1 and hASF1a (显示 ASF1A 抗体) by TLK (显示 TLK2 抗体) kinases.
dASF1 has a direct role in modifying chromatin structure during DNA replication and this function of dASF1 is important for the processivity of the replication machinery.
Asf1 is directed via interactions with sequence-specific complexes to mediate silencing of specific target genes.
Histone chaperones ASF1 and NAP1 (显示 NAP1L1 抗体) differentially modulate removal of active histone marks by LID-RPD3 (显示 HDAC1 抗体) complexes during NOTCH (显示 NOTCH1 抗体) silencing.
Immune suppression of JC virus gene expression is mediated by SRSF1.
ASF/SF2 is identified as a splicing regulator (显示 PTBP2 抗体) of cyclin T1 (显示 CCNT1 抗体), which contributes to the control of the subsequent transcription events.
Findings suggest MALAT1 increases AKAP-9 (显示 AKAP9 抗体) expression by promoting SRPK1 (显示 SRPK1 抗体)-catalyzed SRSF1 phosphorylation in CRC (显示 CALR 抗体) cells. These results reveal a novel molecular mechanism by which MALAT1 regulates AKAP-9 (显示 AKAP9 抗体) expression in CRC (显示 CALR 抗体) cells.
high level of SF2, as a novel oncoprotein in RCC (显示 XRCC1 抗体), was significantly associated with poor survival in a large cohort of RCC (显示 XRCC1 抗体) specimens. Taken together, our study presents a road map for the prediction and validation of miR (显示 MLXIP 抗体)-766-3p/SF2 axis and thus imparts a therapeutic way for further RCC (显示 XRCC1 抗体) progression.
The authors found that RNA recognition motif 1 (RRM1) in SRSF1 binds PP1 and represses its catalytic function through an allosteric mechanism.
We present a joint atomistic molecular dynamics (MD) and experimental study of two RRM-containing proteins bound with their single-stranded target RNAs, namely the Fox-1 (显示 A2BP1 抗体) and SRSF1 complexes.The simulations predict unanticipated specific participation of Arg142 at the protein-RNA interface of the SRFS1 complex, which is subsequently confirmed by NMR and ITC measurements
Using NMR spectroscopy with two separately expressed domains of SRSF1, we showed that several residues in the RNA-binding motif 2 interact with the N-terminal region of the RS domain (RS1 (显示 RS1 抗体)).
Especially, in SRSF1 morphants, bone cartilage formation was reduced in the brain and Nkx-2.5 (显示 NKX2-5 抗体) expression was dramatically reduced in the heart of SRSF1 morphants. In addition, a dramatic reduction in functional chordin (显示 CHRD 抗体) RNA in SRSF1 morphants was observed suggesting that chordin (显示 CHRD 抗体) is one of the targets of SRSF1. Thus, we concluded that SRSF1 is an essential factor for pattern formation including heart, cartilage and germ lay
results strongly support SRSF1 as a prognostic biomarker in SCLC and provide a rationale for personalized therapy in SCLC
NSrp70 (显示 NSRP1 抗体) acts as a new molecular counterpart for alternative splicing of target RNA, counteracting SRSF1 and SRSF2 (显示 SRSF2 抗体) splicing activity.
The expression levels of three splicing factors, ESRP1 (显示 ESRP1 抗体), PTB (显示 PTBP1 抗体) and SF2/ASF, are significantly altered during cardiac hypertrophy in mice.
RRP1B suppresses metastatic progression by altering the transcriptome through its interaction with splicing regulators such as SRSF1
Deletion of RRM1 (显示 RRM1 抗体) eliminated the splicing activity of SRSF1 and thus cellular transformation.
Specific effects on regulated splicing by SR proteins SRSF1 and SRSF2 (显示 SRSF2 抗体) depends on a complex set of relationships with multiple other SR proteins in mammalian genomes.
Treatment with IL-17 (显示 IL17A 抗体) prolongs the half-life of chemokine (显示 CCL1 抗体) CXCL1 (显示 CXCL1 抗体) mRNA via the adaptor TRAF5 (显示 TRAF5 抗体) and the splicing-regulatory factor SF2 (ASF).
analysis of the miRNA-mediated interaction between leukemia/lymphoma-related factor (LRF (显示 ZBTB7A 抗体)) and alternative splicing factor/splicing factor (显示 SLU7 抗体) 2 (ASF/SF2) affects cell senescence and apoptosis
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 (显示 SMN1 抗体) causes spinal muscular atrophy in the absence of SMN1 (显示 SMN1 抗体)
Both hnRNP A1 (显示 HNRNPA1 抗体) and alternative splicing factor/splicing factor (显示 SLU7 抗体) 2 contents rose in adenomas and during injury-induced hyperplasia compared to control lungs
These results highlight the requirement of Sfrs1-mediated alternative splicing for the survival of retinal neurons, with sensitivity defined by the window of time in which the neuron was generated.
This gene encodes a member of the arginine/serine-rich splicing factor protein family, and functions in both constitutive and alternative pre-mRNA splicing. The protein binds to pre-mRNA transcripts and components of the spliceosome, and can either activate or repress splicing depending on the location of the pre-mRNA binding site. The protein's ability to activate splicing is regulated by phosphorylation and interactions with other splicing factor associated proteins. Multiple transcript variants encoding different isoforms have been found for this gene. In addition, a pseudogene of this gene has been found on chromosome 13.
, anti- silencing function 1
, anti-silencing factor
, splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor)
, SR splicing factor 1
, alternative-splicing factor 1
, pre-mRNA-splicing factor SF2, P33 subunit
, splicing factor 2
, splicing factor, arginine/serine-rich 1
, splicing factor arginine/serine-rich 1
, splicing factor, arginine/serine-rich 1B
, pre-mRNA-splicing factor SRp30a
, splicing factor, arginine/serine-rich 1 (ASF/SF2)
, serine/arginine-rich splicing factor 1B
, splicing factor, arginine/serine-rich 1b